PTK2 and breast cancer: Mechanistically, CREB3L1 can promote breast cancer cell invasion and metastasis through inducing ECM production by activating FAK, and a chemical inhibitor of proteases, AEBSF can inhibit breast cancer cell invasion by inhibiting CREB3L1 expression (Feng et al., 2017).